Chargement en cours...
IMMU-45. DOSE MODULATION OF TEMOZOLOMIDE HAVE DISTINCT EFFECTS ON HOST RESPONSE TO PD-1 BLOCKADE
INTRODUCTION: Temozolomide is known to affect efficacy of immunotherapy due to effects on the tumor microenvironment and host immune cell function. The effects of temozolomide dosing on efficacy of immune checkpoint inhibition is unknown. HYPOTHESIS: Dose modification of temozolomide modulates host...
Enregistré dans:
| Publié dans: | Neuro Oncol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216439/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.548 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|